Back to dashboard
CommercialAdministrativeLow impact

11.16.08f, Steroid-Eluting Sinus Stents and Implants

Independence Blue Cross·ENT (Ear, Nose & Throat)·Medical Policy
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

The steroid-eluting sinus stents and implants policy (11.16.08f) has been reissued for commercial plans. This is a policy refresh rather than a substantive change, maintaining existing coverage guidelines for these ENT procedures.

Action Required

Action needed
By April 2, 2025: Review updated policy 11.16.08f for any minor clarifications to steroid-eluting sinus stent coverage criteria. Billing team should verify current prior authorization requirements remain unchanged for these ENT procedures.

Related policy hubs